Parameters | N | Segmental glomerulosclerosis (%) | Global glomerulosclerosis (%) | Crescent (cellular or fibrocellular) (%) | |
---|---|---|---|---|---|
IgA | Mesangial-only | 251 | 9.1 (0.0,18.2) | 12.5 (3.2,27.3) | 0.0 (0.0,6.4) |
 | Mesangial +GCLs | 86 | 11.9 (4.0,20.3) | 13.3 (5.5,30.8) | 0.0 (0.0,9.5) |
 | P |  | 0.094 | 0.469 | 0.107 |
IgG | (−) | 258 | 10.0 (0.0,18.8) | 14.3 (0.0,30.0) | 0.0 (0.0,7.7) |
 | Mesangial-only | 32 | 7.5 (0.0,14.1) | 9.7 (0.0,29.3) | 0.0 (0.0,6.1) |
 | Mesangial +GCLs | 33 | 9.1 (3.9,17.9) | 9.5 (4.2,20.9) | 0.0 (0.0,9.8) |
 | P |  | 0.569 | 0.350 | 0.665 |
IgM | (−) | 199 | 10.0 (0.0,18.7) | 12.5 (4.0,27.6) | 0.0 (0.0,8.3) |
 | Mesangial-only | 102 | 7.7 (0.0,16.2) | 12.5 (0.0,27.6) | 0.0 (0.0,4.0) a |
 | Mesangial +GCLs | 35 | 15.4 (6.7,21.4) | 18.9 (6.2,29.4) | 0.0 (0.0,7.7) |
 | P |  | 0.113 | 0.534 | 0.034 |
C3 | (−) | 162 | 9.3 (0.0,19.6) | 12.5 (4.7,27.2) | 0.0 (0.0,7.3) |
 | Mesangial-only | 127 | 8.3 (0.0,15.4) | 12.5 (0.0,29.0) | 0.0 (0.0,6.7) |
 | Mesangial +GCLs | 46 | 12.5 (6.0,20.0) | 15.6 (6.6,31.4) | 0.0 (0.0,9.6) |
 | P |  | 0.193 | 0.525 | 0.685 |
Fib | (−) | 299 | 10.0 (0.0,18.2) | 12.5 (4.0,28.6) | 0.0 (0.0,7.7) |
 | Mesangial-only | 17 | 10.0 (5.6,26.7) | 15.0 (4.0,27.5) | 0.0 (0.0,7.0) |
 | Mesangial +GCLs | 19 | 9.1 (0.0,17.6) | 20.0 (8.0,24.1) | 0.0 (0.0,5.3) |
 | P |  | 0.526 | 0.833 | 0.836 |
C1q | (−) | 303 | 9.5 (0.0,18.2) | 12.5 (3.7,27.3) | 0.0 (0.0,7.7) |
 | Mesangial-only | 19 | 15.4 (4.8,25.0) | 10.0 (6.2,33.3) | 0.0 (0.0,4.0) |
 | Mesangial +GCLs | 14 | 8.2 (0.0,19.5) | 17.7 (11.8,50.2) | 0.0 (0.0,1.9) |
 | P |  | 0.226 | 0.244 | 0.520 |